Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022. Benjamin DJ, Rezazadeh Kalebasty A. Clin Med Insights Oncol 2024;18:11795549241227413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Benjamin DJ, Rezazadeh Kalebasty A. Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022. Clin Med Insights Oncol 2024;18:11795549241227413.
PMID: 38322668